SAN

100.12

-2.11%↓

SHL.DE

49.82

-0.88%↓

ARGX

531.2

-2.57%↓

FRE

39.38

-0.56%↓

PHIA

22.86

-3.01%↓

SAN

100.12

-2.11%↓

SHL.DE

49.82

-0.88%↓

ARGX

531.2

-2.57%↓

FRE

39.38

-0.56%↓

PHIA

22.86

-3.01%↓

SAN

100.12

-2.11%↓

SHL.DE

49.82

-0.88%↓

ARGX

531.2

-2.57%↓

FRE

39.38

-0.56%↓

PHIA

22.86

-3.01%↓

SAN

100.12

-2.11%↓

SHL.DE

49.82

-0.88%↓

ARGX

531.2

-2.57%↓

FRE

39.38

-0.56%↓

PHIA

22.86

-3.01%↓

SAN

100.12

-2.11%↓

SHL.DE

49.82

-0.88%↓

ARGX

531.2

-2.57%↓

FRE

39.38

-0.56%↓

PHIA

22.86

-3.01%↓

Search

EssilorLuxottica SA

Abierto

SectorSalud

267.1 -0.15

Resumen

Variación precio

24h

Actual

Mínimo

264.3

Máximo

268.5

Métricas clave

By Trading Economics

Ingresos

-371M

994M

Ventas

-72M

13B

P/B

Media del Sector

52.729

73.239

BPA

2.976

Rentabilidad por dividendo

1.48

Margen de beneficio

7.52

Empleados

153,498

EBITDA

635M

3.6B

Recomendaciones

By TipRanks

Recomendaciones

Comprar

Estimación a 12 meses

+8.59% upside

Dividendos

By Dow Jones

Rentabilidad por dividendo

Media del Sector

1.48%

3.06%

Próximas Ganancias

17 abr 2025

Estadísticas de Mercado

By TradingEconomics

Capitalización de Mercado

2.3B

124B

Apertura anterior

267.25

Cierre anterior

267.1

Noticias sobre sentimiento de mercado

By Acuity

36%

64%

118 / 386 Clasificación en Healthcare

Puntuación técnica

By Trading Central

Confianza

Strong Bearish Evidence

EssilorLuxottica SA Gráfico

El rendimiento pasado no es un indicador fiable de resultados futuros.

Noticias Relacionadas

12 feb 2025, 18:35 UTC

Ganancias

Ray-Ban Maker EssilorLuxottica Logs Higher Sales Amid North America, China Growth -- Update

12 feb 2025, 17:32 UTC

Ganancias

Ray-Ban Maker EssilorLuxottica Posts Higher Profit on Sales Growth

2 ene 2025, 17:29 UTC

Adquisiciones, fusiones, absorciones

EssilorLuxottica Buys AI Startup in Hearing Market Push

28 mar 2025, 08:57 UTC

Charlas de Mercado

EssilorLuxottica Should Be Able to Cope With U.S. Volatility -- Market Talk

13 feb 2025, 11:05 UTC

Charlas de Mercado
Ganancias

EssilorLuxottica Seems Poised to Ride the Technology Wave -- Market Talk

13 feb 2025, 10:54 UTC

Charlas de Mercado
Ganancias

EssilorLuxottica's Midterm Margin Target Seems Challenging -- Market Talk

13 feb 2025, 08:41 UTC

Charlas de Mercado
Ganancias

EssilorLuxottica's Sales Are Better Than Expected -- Market Talk

12 feb 2025, 17:05 UTC

Ganancias

EssilorLuxottica Backs Mid-Term Targets

12 feb 2025, 17:05 UTC

Ganancias

EssilorLuxottica 2024 Oper Pft EUR3.45B

12 feb 2025, 17:04 UTC

Ganancias

Analysts Had Seen EssilorLuxottica 2024 Net Pft at EUR2.50B

12 feb 2025, 17:04 UTC

Ganancias

EssilorLuxottica 2024 Net Pft EUR2.36B

12 feb 2025, 17:03 UTC

Ganancias

EssilorLuxottica 2024 Rev EUR26.51B

12 feb 2025, 17:03 UTC

Ganancias

EssilorLuxottica 4Q Rev EUR6.78B

12 feb 2025, 17:01 UTC

Ganancias

Analysts Had Seen EssilorLuxottica 4Q Rev at EUR6.68B

12 feb 2025, 17:00 UTC

Ganancias

EssilorLuxottica Declares Dividend of EUR3.95 a share

11 feb 2025, 16:30 UTC

Charlas de Mercado

EssilorLuxottica Has Bright Future Ahead Amid Smart Glasses Push -- Market Talk

11 feb 2025, 10:58 UTC

Charlas de Mercado
Adquisiciones, fusiones, absorciones

EssilorLuxottica Continues Ophthalmology Expansion With Cellview Acquisition -- Market Talk

11 feb 2025, 07:03 UTC

Adquisiciones, fusiones, absorciones

EssilorLuxottica Doesn't Disclose Financial Details

11 feb 2025, 07:03 UTC

Adquisiciones, fusiones, absorciones

EssilorLuxottica Aims to Build Wider Portfolio of Ophthalmic Instruments, Services With Deal

11 feb 2025, 07:02 UTC

Adquisiciones, fusiones, absorciones

EssilorLuxottica: Toronto-Based Cellview Specializes in Diagnostic via Retinal Imaging

11 feb 2025, 07:01 UTC

Adquisiciones, fusiones, absorciones

EssilorLuxottic Acquires Canadian Med-Tech Startup Cellview

11 feb 2025, 07:00 UTC

Adquisiciones, fusiones, absorciones

EssilorLuxottica to Buy Cellview

2 ene 2025, 17:04 UTC

Adquisiciones, fusiones, absorciones

EssilorLuxottica Didn't Disclose Financial Details

2 ene 2025, 17:03 UTC

Adquisiciones, fusiones, absorciones

EssilorLuxottica: This Allows People With Hearing Impairment to Better Understand Speech

2 ene 2025, 17:02 UTC

Adquisiciones, fusiones, absorciones

EssilorLuxottica: Pulse Audition Delivers AI-based Noise Reduction, Voice Enhancement

2 ene 2025, 17:01 UTC

Adquisiciones, fusiones, absorciones

EssilorLuxottica Acquires Pulse Audition

2 ene 2025, 17:00 UTC

Adquisiciones, fusiones, absorciones

EssilorLuxottica Strengthens Its Presence in Hearing Space With Acquisition of AI-driven Tech Startup in France

3 dic 2024, 16:21 UTC

Charlas de Mercado

EssilorLuxottica Could Be Hit by U.S. Tariffs -- Market Talk

6 nov 2024, 09:01 UTC

Charlas de Mercado

European Luxury Stocks Get Boost From Trump Potential Win -- Market Talk

18 oct 2024, 07:08 UTC

Charlas de Mercado
Ganancias

EssilorLuxottica Tries Soothe Nerves After Revenue Misses Forecasts -- Market Talk

Comparación entre iguales

Cambio de precio

EssilorLuxottica SA Esperado

Precio Objetivo

By TipRanks

8.59% repunte

Estimación a 12 meses

Media 288.2 EUR  8.59%

Máximo 335 EUR

Mínimo 245 EUR

De acuerdo con 11 analistas de Wall Street que ofrecen objetivos de precios a 12 meses para EssilorLuxottica SA Dist en los últimos 3 meses.

Consenso

By TipRanks

Comprar

11 ratings

7

Comprar

4

Mantener

0

Vender

Puntuación técnica

By Trading Central

265.8 / 267.9Soporte y Resistencia

Corto Plazo

Strong Bearish Evidence

Medio plazo

Strong Bearish Evidence

Largo Plazo

No Evidence

Sentimiento

By Acuity

118 / 386 Clasificación en Salud

Noticias sobre sentimiento de mercado

Coyuntura alcista

Volatilidad

Por debajo de la media

Volumen de Noticias (RCV)

Por encima de la media

Finanzas

Gastos de venta y administración

Gastos operativos

Beneficio antes de impuestos

Ventas

Coste de ventas

Beneficio bruto de ventas

Gasto por intereses de deuda

EBITDA

Beneficio operativo

$

Acerca de EssilorLuxottica SA

EssilorLuxottica Société anonyme designs, manufactures, and distributes ophthalmic lenses, frames, and sunglasses in Europe, the Middle East, Africa, Latin America, the Asia-Pacific, and North America. It operates through Professional Solutions and Direct to Consumer segments. The company offers lens under the Essilor, Varilux, Crizal, Eyezen, Stellest, Xperio, Transitions, Ray-Ban, Oakley, Barberini, KODAK Lens, Nikon, Shamir, eyexpert, iWear, Humanware, and Optifog brands. It also provides finishing equipment, vision performance screening, eye examination and refractions, fitting parameter measurements, and small tools and consumables under the Essilor Instruments brand; high-tech equipment for optical surfacing, polishing, measuring, coating, and finishing, as well as consumables, tools, and services under the Satisloh brand. In addition, the company provides eyewear products under the Ray-Ban, Oakley, Persol, Oliver Peoples, Vogue Eyewear, Arnette, Alain Mikli, Costa, Bliz, Native, Luxottica, Sferoflex, Bolon, Molsion, DbyD, and Unofficial and Seen, as well as other Licensed brands. In addition, the company designs, develops, markets, and maintains lens edging and mounting instruments for opticians and prescription laboratories; and optometry instruments for eyecare professionals, schools, occupational medicine centers, military, and other institutions. It wholesales its products to independent opticians, distributors, third-party e-commerce platforms, and large retail chains in the eyecare and eyewear industry; and sells directly to consumers through the network of brick and mortar retail network and its online channels. The company was formerly known as Essilor International Société Anonyme and changed its name to EssilorLuxottica Société anonyme in October 2018. EssilorLuxottica Société anonyme was founded in 1849 and is headquartered in Paris, France.